Balloon pump may boost ECMO success in shock patients
NCT ID NCT05913622
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tests whether adding an intra-aortic balloon pump (IABP) to standard ECMO support helps more people with severe cardiogenic shock recover enough to come off the heart-lung machine. About 430 adults will be randomly assigned to get ECMO alone or ECMO plus IABP. The main goal is to see who can be weaned from ECMO within 30 days without needing a heart transplant or permanent heart pump.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ Sint-Jan Brugge
RECRUITINGBruges, Belgium
-
Amphia hospital
NOT_YET_RECRUITINGBreda, North Brabant, 4818 CK, Netherlands
-
Amsterdam University Medical Center
NOT_YET_RECRUITINGAmsterdam, North Holland, 1105 AZ, Netherlands
-
Antonius hospital
NOT_YET_RECRUITINGNieuwegein, Utrecht, 3435 CM, Netherlands
-
Catharina hospital
NOT_YET_RECRUITINGEindhoven, North Brabant, 5623 EJ, Netherlands
-
Erasmus Medical Center
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Haga ziekenhuis
NOT_YET_RECRUITINGThe Hague, South Holland, 2545 AA, Netherlands
-
Leiden University Medical Center
NOT_YET_RECRUITINGLeiden, South Holland, 2333 ZA, Netherlands
-
Maastricht UMC
RECRUITINGMaastricht, Netherlands
-
OLVG
RECRUITINGAmsterdam, Netherlands
-
Radboud UMC
RECRUITINGNijmegen, Netherlands
-
UZ Gent
RECRUITINGGhent, Belgium
-
University Medical Center Utrecht
NOT_YET_RECRUITINGUtrecht, Utrecht, 3584 CX, Netherlands
-
ZOL Genk
RECRUITINGGenk, Belgium
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Intra-aortic balloon pump (IABP)
What this could lead to
If it works, this could show that adding an IABP helps more patients successfully come off ECMO without needing a heart transplant or long-term heart pump.
What could go wrong
This is an early-stage platform trial, so results may not be definitive. The IABP itself carries risks like bleeding or vessel damage, and the benefit over ECMO alone is unproven.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.